Yarrow Bioscience, Inc.

Yarrow Bioscience, Inc.

NNASDAQ:YARW
13.93
USD
-4.10
(-22.74%)
-188.57EPS
91.20MMarket Cap
Mar 04Next Earn

Income Statement (USD)

No data availableFinancial data will appear here once available

Balance Sheet (USD)

2025 Y
As of date
12/31/2025
Total Current Assets
100
+ Cash, Cash Equivalents & STI
100
+ Cash & Cash Equivalents
100
+ ST Investments
- -
+ Accounts & Notes Receiv
- -
+ Accounts Receivable, Net
- -
+ Notes Receivable, Net
- -
+ Loans Receivable, Net
- -
+ Other Receivable, Net
- -
+ Inventories
- -
+ Raw Materials
- -
+ Work In Process
- -
+ Finished Goods
- -
+ Inventory Adjustments
- -
+ Other Inventory
- -
+ Other ST Assets
- -
+ Misc ST Assets
- -
+ Prepaid Expenses
- -
+ ST Derivative & Hedging Assets
- -
+ ST Assets Held-for-Sale
- -
+ ST Deferred Tax Assets
- -
Total Noncurrent Assets
- -
+ Property, Plant & Equip, Net
- -
+ Property, Plant & Equip
- -
- Accumulated Depreciation
- -
+ LT Investments & Receivables
- -
+ LT Investments
- -
+ LT Receivables
- -
+ Other LT Assets
- -
+ Total Intangible Assets
- -
+ Goodwill
- -
+ Other Intangible Assets
- -
+ LT Deferred Tax Assets
- -
+ LT Derivative & Hedging Assets
- -
+ Misc LT Assets
- -
Total Assets
100
+ Payables & Accruals
72
+ Accounts Payable
2
+ Accrued Taxes
- -
+ Interest & Dividends Payable
- -
+ Other Payables & Accruals
70
+ ST Debt
- -
+ ST Borrowings
- -
+ ST Finance Leases
- -
+ Other ST Liabilities
- -
+ Deferred Revenue
- -
+ Derivatives & Hedging
- -
+ Deferred Tax Liabilities
- -
+ Misc ST Liabilities
- -
Total Current Liabilities
72
+ LT Debt
- -
+ LT Borrowings
- -
+ LT Finance Leases
- -
+ Other LT Liabilities
- -
+ Accrued Liabilities
- -
+ Pension Liabilities
- -
+ Deferred Revenue
- -
+ Deferred Tax Liabilities
- -
+ Derivatives & Hedging
- -
+ Misc LT Liabilities
- -
Total Noncurrent Liabilities
- -
Total Liabilities
72
+ Preferred Equity and Hybrid Capital
100
+ Share Capital & APIC
- -
+ Common Stock
- -
+ Additional Paid in Capital
- -
- Treasury Stock
- -
+ Retained Earnings
-71
+ Other Equity
- -
Equity Before Minority Interest
29
+ Minority/Non Controlling Interest
- -
Total Equity
29
Total Liabilities & Equity
100
Shares Outstanding
3
Number of Employees
10
Capital Leases - Total
- -
Net Debt
-100
Net Debt to Equity
-346.48
Tangible Common Equity Ratio
-70.7
Current Ratio
1.4
Cash Conversion Cycle
- -

Cash Flow Statement (USD)

No data availableFinancial data will appear here once available